Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Submissions are now closed - Results will be announced end of December.
The EHRA Innovation Stage is for clinicians, scientists and engineers. The invention or innovation should be on the broad topic of cardiac arrhythmias and tackle a novel approach.
It could be a developed software, a new device, a new use for a drug or other small molecule, or bringing a business approach to an aspect of cardiac rhythm management that can be considered an invention.
All pre-commercial revenue stages will be considered, so the idea may be still in basic research, or have progressed all the way to early clinical trials, but it should have moved beyond the idea stage.
Four 50-minutes sessions will be organised at the Innovation Stage during the coffee breaks. Four inventors will present their innovation during seven minutes followed by five minutes discussion. The session will be animated by the chairperson and two discussants will ask questions to the presenters. There is also time for questions from the audience.
The three best innovations will have the opportunity to present their work again during the EHRA Innovation Stage Final.
The top three presenters will be awarded a certificate and a free registration to attend EHRA 2021.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.